Abstract

With the efficacy and costs of medications rising rapidly, it is increasingly important to ensure that drugs be prescribed as rationally as possible. Yet, physicians' choices of drugs frequently fall short of the ideal of precise and cost-effective decision making. Evidence indicates that such decisions can be improved in a variety of ways. A number of theories and principles of communication and behavior changes can be found that underlie the success of pharmaceutical manufacturers in influencing prescribing practices. Based on this behavioral science and several field trials, it is possible to define the theory and practice of methods to improve physicians' clinical decision making to enhance the quality and cost-effectiveness of care. Some of the most important techniques of such "academic detailing" include (1) conducting interviews to investigate baseline knowledge and motivations for current prescribing patterns, (2) focusing programs on specific categories of physicians as well as on their opinion leaders, (3) defining clear educational and behavioral objectives, (4) establishing credibility through a respected organizational identity, referencing authoritative and unbiased sources of information, and presenting both sides of controversial issues, (5) stimulating active physician participation in educational interactions, (6) using concise graphic educational materials, (7) highlighting and repeating the essential messages, and (8) providing positive reinforcement of improved practices in follow-up visits. Used by the nonprofit sector, the above techniques have been shown to reduce inappropriate prescribing as well as unnecessary health care expenditures.

Highlights

  • In one study of educational out¬ reach, two brief visits to physicians by clinical pharmacists trained in effective techniques of communication and per¬ suasion as well as pharmacotherapy were found to reduce inappropriate pre¬ scribing of cerebral vasodilators, cephalexin, and propoxyphene by 14% in com¬ parison with controls (P=.0001).[4]

  • While important dif¬ ferences exist between pharmaceutical marketing and medical education or quality assurance, there is reason to be¬ lieve that many of the techniques de¬ scribed below could be adapted to such purposes

  • Our goal is to identify those aspects of detailing that can be put in the service of supporting the physician in making better therapeutic decisions, while leaving aside any techniques that might be manipulative or serve only to increase sales of a given product

Read more

Summary

Published Version Citable link Terms of Use

A number of theories and principles of communication and behavior change can be found that underlie the success of pharmaceutical manufacturers in influencing prescribing practices Based on this behavioral science and several field trials, it is possible to define the theory and practice of methods to improve physicians' clinical decision making to enhance the quality and cost-effectiveness of care. The following analysis of common techniques and principles employed by such change-agents are based on indepth interviews with and videotapes of former pharmaceutical representa¬ tives, other written accounts of the de¬ tailing process, and our own experience in mounting several trials of "public in¬ terest detailing" in five states to reduce excessive or inappropriate prescrib¬.

BEHAVIOR CHANGE STRATEGIES
Defining Specific Problems and Objectives
Market Research
Establishing Credibility
Promoting Active Learner
Repetition and Reinforcement
Brief Graphic Print Materials
Findings
Offering Practical Alternatives
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call